SCHEMBL21557634

SCHEMBL21557634

FC1CN(c2cnc3c(c2)c(I)cn3S)CC(F)(F)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21557943 0.76 MAPK1 (0.38) —
SCHEMBL21557955 0.75 — —
SCHEMBL22403200 0.74 MAPK1 (0.35) —
SCHEMBL22403131 0.74 MAPK1 (0.35) —
SCHEMBL21557649 0.74 MAPK1 (0.35) —
SCHEMBL22403197 0.74 MAPK1 (0.35) —
SCHEMBL21557845 0.74 RAB9A (0.40) —
SCHEMBL21557940 0.74 RAB9A (0.40) —
SCHEMBL18892001 0.73 CHRNB2 (0.37) —
SCHEMBL18891808 0.72 ACVR1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377491-B1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV DISCOVERY (FR) 2019-11-13 — — EP disclosed
Send feedback